Abstract
The in vitro activity of sparfloxacin (CI-978, AT-4140), a new quinolone which is active against gram-negative and gram-positive bacteria, and nine other broad-spectrum antibiotics was tested against 128 gram-negative nosocomial bloodstream isolates from separate patients. Sparfloxacin and ciprofloxacin were among the most potent antibiotics againstEscherichia coli (n=40),Enterobacter cloacae (n=18),Klebsiella oxytoca (n=13), andKlebsiella pneumoniae (n=19), with MIC90 values of ≤ 0.25 µg/ml. Ciprofloxacin was slightly more potent than sparfloxacin againstSerratia marcescens (n=14), the MIC90 values being 0.25 and 1.0 µg/ml respectively, although all strains were susceptible to both agents. Sparfloxacin was slightly less potent than ciprofloxacin againstPseudomonas aeruginosa (n=24), the MIC90 values being 4.0 and 0.5 µg/ml respectively. Overall, the in vitro activity of sparfloxacin compared favorably with that of ciprofloxacin and the other broad spectrum agents tested against nosocomial gram-negative bloodstream isolates.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
McGowan JE, Barnes MW, Finland M: Bacteremia at Boston City Hospital: occurrence and mortality during 12 selected years (1935–1972) with special reference to hospital-acquired cases. Journal of Infectious Diseases 1975, 132: 316–335.
Wenzel RP: The mortality of hospital-acquired bloodstream infections: need for a new vital statistic? International Journal of Epidemology 1988, 17: 225–227.
Nakamura S, Minami A, Nakata K, Kurobe N, Kouno K, Sakaguchi Y, Kashimoto S, Yoshida H, Kojima T, Ohue T, Fujimoto K, Nakamura M, Hashimoto M, Shimizu M: In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone. Antimicrobial Agents and Chemotherapy 1989, 33: 1167–1173.
Kojima T, Inoue M, Mitsuhashi S: In vitro activity of AT-4140 against clinical bacterial isolates. Antimicrobial Agents and Chemotherapy 1989, 33: 1980–1988.
Barry AL: The antimicrobic susceptibility test: principles and practices. Lea & Febiger, Philadelphia, PA, 1986.
National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically (tentative standard). Publication M7-T2. NCCLS, Villanova, PA, 1988.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Doebbeling, B.N., Pfaller, M.A., Bale, M.J. et al. Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates. Eur. J. Clin. Microbiol. Infect. Dis. 9, 298–301 (1990). https://doi.org/10.1007/BF01968067
Issue Date:
DOI: https://doi.org/10.1007/BF01968067